Mark Pollack to Benzodiazepines
This is a "connection" page, showing publications Mark Pollack has written about Benzodiazepines.
Connection Strength
2.235
-
Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluation. Behav Res Ther. 2010 Aug; 48(8):720-7.
Score: 0.367
-
Benzodiazepines in clinical practice: consideration of their long-term use and alternative agents. J Clin Psychiatry. 2005; 66 Suppl 2:21-7.
Score: 0.254
-
Internal cue exposure and the treatment of substance use disorders: lessons from the treatment of panic disorder. J Anxiety Disord. 2004; 18(1):69-87.
Score: 0.237
-
Long-term management of panic disorder. J Clin Psychiatry. 2004; 65 Suppl 5:24-8.
Score: 0.237
-
WCA recommendations for the long-term treatment of panic disorder. CNS Spectr. 2003 Aug; 8(8 Suppl 1):17-30.
Score: 0.230
-
The pharmacotherapy of panic disorder. Bull Menninger Clin. 1996; 60(2 Suppl A):A54-75.
Score: 0.136
-
Refractory generalized anxiety disorder. J Clin Psychiatry. 2009; 70 Suppl 2:32-8.
Score: 0.084
-
An open-label trial of risperidone augmentation for refractory anxiety disorders. J Clin Psychiatry. 2006 Mar; 67(3):381-5.
Score: 0.069
-
Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled study. Biol Psychiatry. 2006 Feb 01; 59(3):211-5.
Score: 0.067
-
Discussion: using benzodiazepines in clinical practice. J Clin Psychiatry. 2005; 66 Suppl 2:39-43; quiz 44-5.
Score: 0.064
-
The pharmacotherapy of panic disorder. J Clin Psychiatry. 2005; 66 Suppl 4:23-7.
Score: 0.064
-
WCA recommendations for the long-term treatment of social phobia. CNS Spectr. 2003 Aug; 8(8 Suppl 1):40-52.
Score: 0.058
-
WCA recommendations for the long-term treatment of generalized anxiety disorder. CNS Spectr. 2003 Aug; 8(8 Suppl 1):53-61.
Score: 0.058
-
Longitudinal outcome with pharmacotherapy in a naturalistic study of panic disorder. J Affect Disord. 2002 May; 69(1-3):201-8.
Score: 0.053
-
Social anxiety disorder: designing a pharmacologic treatment strategy. J Clin Psychiatry. 1999; 60 Suppl 9:20-6.
Score: 0.042
-
Long-term course and outcome of panic disorder. J Clin Psychiatry. 1997; 58 Suppl 2:57-60.
Score: 0.036
-
Integrated treatment of panic disorder. Bull Menninger Clin. 1995; 59(2 Suppl A):A4-26.
Score: 0.032
-
Integration of behavioral and pharmacological treatments for panic disorder: implications for the treatment of substance dependence. NIDA Res Monogr. 1995; 150:143-66.
Score: 0.032
-
Innovative uses of benzodiazepines in psychiatry. Can J Psychiatry. 1993 Nov; 38 Suppl 4:S122-6.
Score: 0.029
-
Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder. Am J Psychiatry. 1993 Oct; 150(10):1485-90.
Score: 0.029
-
Aripiprazole as augmentation treatment of refractory generalized anxiety disorder and panic disorder. CNS Spectr. 2008 Jun; 13(6):522-7.
Score: 0.020
-
Clinician response to treatment refractory panic disorder: a survey of psychiatrists. J Nerv Ment Dis. 1999 Dec; 187(12):755-7.
Score: 0.011
-
Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: a clinical case series. Behav Res Ther. 1999 Aug; 37(8):763-70.
Score: 0.011
-
Dizziness and panic disorder: a review of the association between vestibular dysfunction and anxiety. Ann Clin Psychiatry. 1998 Jun; 10(2):75-80.
Score: 0.010
-
Cognitive-behavioral therapy for benzodiazepine discontinuation in panic disorder patients. Psychopharmacol Bull. 1992; 28(2):123-30.
Score: 0.006